russell

The Week Ahead: Breakout As Expected — So What’s Next?

In last week’s Fakeout or Breakout? I made the case based on the technical evidence that “despite Friday’s drop, I expect last week’s highs in the major averages to be surpassed in the coming weeks.” As you may recall, the S&P 500 was down over 1% on Friday April 17 and the bearish sentiment spiked.In last Thursday’s trading, the NYSE […]

STTG Market Recap Mar 24, 2015 – Stock Trading To Go

Quick note from Blain: US Investing Champions Mark Minervini and David Ryan (read my review of the workshop) are doing a webinar tomorrow (Wednesday) at 4:30 PM EST. Pretty rare, in fact this is the first one they’ve ever done together. Here’s the link to sign up if you’re interested. I’ll be tuning in myself.Inflation data caused a bit of […]

Why Yellen & The Feds Are Bubble Blind – They Apparently Believe Wall Street’s EPS Scam

Submitted by David Stockman via Contra Corner blog,Surveying the Fed’s handiwork during last week’s press conference, Janet Yellen noted that all was awesome except that stocks were now slightly “on the high side” of their historical range. You can say that again!In fact, you can say that any one capable of uttering such tommyrot has been totally bamboozled by Wall […]

The Amazing Run In Biotech Stocks | See It Market

Biotech stocks have been on fire in 2015. In the Biotech & Pharmaceuticals sector of the Russell 2000 Growth Index, there are over sixty stocks up by more than 30% this year. More than thirty stocks are up greater than 50% while six have more than doubled.The iShares Biotechnology ETF (IBB) is already up more than 20% less than 3 […]

URGENT: Take Profits on These 3 Trades

I’m baaaack…Yep – back in the saddle after roughing it in the desert for a week. I fended off mountain lion attacks…lost a few bucks betting on March Madness during a detour to Vegas…and meditated on the markets while staring up at the stars.Stocks stabilized in my absence after wandering lower during that pesky early-March pullback. The major averages aren’t […]

Profit From The Next Major Stock Market Correction – ETF Daily News

George Leong:  The stock market continues to want to edge higher, but beware. I still sense there will be more downside moves that will provide a trading opportunity. At this juncture, I would be looking for sell-offs in the stock market and chaos.Just like what we saw in 2008 when the stock market and big banks crashed, when a stock market […]

Light Volume Session as Market digests Fed Meeting

As March Madness begins the market had a solid quiet inside consolidation day.  Biotech stocks were once again the talk of the town as many stocks were jumping higher.  Once again small cap stocks were the winners today with the NASDAQ Composite just behind.  The Dow led to the downside as pressure from a rising dollar continues to be the […]

Goldman Sachs: Small-Cap Valuations ‘Still Stretched’

Federal Reserve Chairwoman Janet Yellen last week said small-cap stocks appeared to be “substantially stretched.” Now, Goldman Sachs (GS) is on board with a similar view.In a note to clients, Goldman strategist David Kostin said he expects the small-cap Russell 2000 will underperform the S&P 500 over the next 12 months due to pricey valuations and lower earnings forecasts. He […]

Stocks Fluctuate After Rally as Biotech Advances

© Carlo Allegri/Reuters A trader works on the floor of the New York Stock Exchange on the last day of trading before Christmas in the Manhattan borough of New York, December 24, 2014.U.S. stocks fluctuated, with the Standard & Poor’s 500 Index (SPX) poised for a third straight yearly gain as equity gauges climbed past multiple milestones last week.Gilead […]

Stocks Lose Their Bounce

Stocks gapped up at the open, in what appeared to be another buy-the-dip reversal. Sellers saw the higher open as an opportunity to sell at higher prices than Friday. Trading volume was heavy and the selling pressure was steady. Biotechs and small caps participated in the selling today, as did leading stocks. Still, we are right about at the point […]